1. Home
  2. ROIV

as 10-03-2025 4:00pm EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Founded: 2014 Country:
United Kingdom
United Kingdom
Employees: N/A City: LONDON
Market Cap: 8.6B IPO Year: N/A
Target Price: $19.94 AVG Volume (30 days): 9.5M
Analyst Decision: Strong Buy Number of Analysts: 8
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.69 EPS Growth: N/A
52 Week Low/High: $8.73 - $16.19 Next Earning Date: 11-11-2025
Revenue: $23,233,000 Revenue Growth: -35.86%
Revenue Growth (this year): -14.21% Revenue Growth (next year): 248.22%

ROIV Daily Stock ML Predictions

Stock Insider Trading Activity of Roivant Sciences Ltd. (ROIV)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Venker Eric ROIV President & Immunovant CEO Sep 23 '25 Sell $14.83 611,000 $9,061,130.00 1,504,959
Venker Eric ROIV President & Immunovant CEO Sep 22 '25 Sell $15.00 416,182 $6,240,568.18 1,504,959
Venker Eric ROIV President & Immunovant CEO Sep 19 '25 Sell $14.95 683,818 $10,223,079.10 1,504,959
Gline Matthew ROIV CEO Sep 18 '25 Buy $15.07 3,315 $49,957.05 17,287,081
Ramaswamy Vivek ROIV 10% Owner Sep 5 '25 Sell $12.96 385,816 $5,000,175.36 35,508,359
Ramaswamy Vivek ROIV 10% Owner Sep 4 '25 Sell $12.92 194,933 $2,518,534.36 35,508,359
Ramaswamy Vivek ROIV 10% Owner Sep 3 '25 Sell $12.50 1,195,000 $14,937,500.00 35,508,359
Venker Eric ROIV President & Immunovant CEO Aug 20 '25 Sell $11.72 100,000 $1,172,000.00 1,504,959

Share on Social Networks: